Cuba’s medical internationalism
“Whoever cannot fight for others will never be sufficiently able to fight for themselves.”
(CIGB) The human Recombinant Interferon alfa-2B, developed in 1986 by a team of researchers from the Center for Genetic Engineering and Biotechnology (CIGB in its Spanish acronym), has benefitted thousands of Cuban patients since its inception in the Cuban health system more than three decades ago, and is one of the medicines being currently used to combat the novel coronavirus COVID-19.
To date, Cuba has not made the decision to close our borders to travelers from any country, but careful follow-up has been established for all passengers, especially those arriving from high risk nations.
At Havana's José Martí International Airport, the flow of travelers continues to be normal, and no flights have been cancelled, to date. Surveillance measures, however, are being reinforced, based on the confirmation of Covid-19 cases in Cuba.